Literature DB >> 8484080

The intensity and variability of symptoms in dyspepsia.

T Johannessen1, H Petersen, P Kristensen, P M Kleveland, J Dybdahl, A K Sandvik, E Brenna, H Waldum.   

Abstract

During the waiting time for upper gastrointestinal endoscopy 165 patients with dyspepsia completed a questionnaire and a diary for daily measurements of the symptoms pain, heartburn, and global complaints. 23 patients (14%) had peptic ulcer disease (PUD), 18 oesophagitis (11%), and the rest were labelled nonulcer dyspepsia (NUD). NUD was further subdivided into ulcer-like, reflux-like, dysmotility, and essential NUD by means of predefined symptom profiles. 39 (24%) patients were on H2 receptor antagonist treatment. In general, the intensity of the daily symptoms was rather low, and except for a higher rating of heartburn in oesophagitis, there were no significant differences between PUD, oesophagitis, and NUD--treated or untreated. NUD patients with reflux-like dyspepsia had significantly more heartburn than the group with essential NUD; otherwise there were no differences between the subgroups of NUD. The individual daily ratings for abdominal pain, heartburn, and global symptoms varied by an average standard deviation of 64%, 97% and 47% of the mean values, respectively, and were independent of treatment or diagnoses. There was an approximately 40% probability that two successive days had different levels of symptoms. Only 10% of the patients showed stable symptoms, and the patients were completely symptom-free for 20% of the observation period. Symptoms in dyspepsia patients disclosed low intensity and high variability in this study. Such factors may be important sources of bias in clinical trials.

Entities:  

Mesh:

Year:  1993        PMID: 8484080     DOI: 10.3109/02813439308994902

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  5 in total

Review 1.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.

Authors:  Johanna I Westbrook; Anne E Duggan; John M Duggan; Mary T Westbrook
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

Review 4.  Management of functional dyspepsia: Unsolved problems and new perspectives.

Authors:  Ahmed Madisch; Stephan Miehlke; Joachim Labenz
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

5.  Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool.

Authors:  Herdis K M Molinder; Lars Kjellström; Henry B O Nylin; Lars E Agréus
Journal:  Health Qual Life Outcomes       Date:  2009-12-29       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.